D
Arcellx, Inc. ACLX
$66.49 -$0.12-0.18% NASDAQ
Recommendation
Prev Close
$66.61
Volume
13,402
Avg Vol (90D)
728,031
Market Cap
$3.67B
Dividend & Yield
--
52-Week Range
$47.86 - $107.37
P/E (TTM)
--
EPS (TTM)
-$2.99
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Cantor Fitzgerald Comments on Arcellx FY2026 Earnings
6/10/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Two Sigma Investments LP
6/9/2025 - MarketBeat
Arcellx FY2026 EPS Estimate Increased by Leerink Partnrs
6/6/2025 - MarketBeat
Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX)
6/6/2025 - MarketBeat
Arcellx FY2029 EPS Forecast Increased by Leerink Partnrs
6/5/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Rating of "Buy" from Brokerages
6/3/2025 - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $20.51 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX)
5/29/2025 - MarketBeat
Arcellx Inc Holds Annual Stockholders Meeting
5/28/2025 - TipRanks Financial Blog
Voloridge Investment Management LLC Boosts Holdings in Arcellx, Inc. (NASDAQ:ACLX)
5/26/2025 - MarketBeat
Arcellx (NASDAQ:ACLX) Stock Price Up 6% - Here's Why
5/23/2025 - MarketBeat
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
5/23/2025 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
5/23/2025 - CNW Group - News Releases
Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its ...
5/21/2025 - GuruFocus
Arcellx Inc (ACLX) Announces Participation in Key Investor Events ACLX stock news
5/21/2025 - GuruFocus
Arcellx Announces Its Participation at TD Cowens 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025
5/21/2025 - Business Wire
Arcellx (ACLX, $60.54) entered Uptrend as Momentum indicator ascends above 0 level on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Vestal Point Capital LP Decreases Stake in Arcellx, Inc. (NASDAQ:ACLX)
5/21/2025 - MarketBeat
Insider Selling: Arcellx, Inc. (NASDAQ:ACLX) Director Sells 1,500 Shares of Stock
5/21/2025 - MarketBeat
BNP Paribas Financial Markets Makes New $1.53 Million Investment in Arcellx, Inc. (NASDAQ:ACLX)
5/21/2025 - MarketBeat
Baron Discovery Fund Initiated a Position in Arcellx (ACLX)
5/20/2025 - Yahoo! Finance: News
Baron Discovery Fund Initiated a Position in Arcellx (ACLX)
5/20/2025 - Insider Monkey
Tema Etfs LLC Takes $573,000 Position in Arcellx, Inc. (NASDAQ:ACLX)
5/20/2025 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE)
5/19/2025 - TipRanks Financial Blog
Paradigm Biocapital Advisors LP Reduces Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)
5/16/2025 - MarketBeat
Nicholas Investment Partners LP Purchases 11,500 Shares of Arcellx, Inc. (NASDAQ:ACLX)
5/16/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$76.81M
EBITDA (TTM)
-$184.72M
EBIT (TTM)
-$190.66M
Net Income (TTM)
-$162.42M
Balance Sheet
Total Assets (Q)
$648.08M
Total Debt (Q)
$53.19M
Total Liabilities (Q)
$231.18M
Book Value Per Share (Q)
$7.57
Cash Flow
Cash from Operations (TTM)
-$114.71M
Cash from Investing (TTM)
$61.55M
Cash from Financing (TTM)
-$20.56M
Net Change in Cash (TTM)
-$73.71M
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
1.60
7-Day Total Return
7.36%
30-Day Total Return
2.75%
60-Day Total Return
-8.59%
90-Day Total Return
-2.41%
Year to Date Total Return
-15.57%
1-Year Total Return
23.13%
2-Year Total Return
66.89%
3-Year Total Return
206.26%
5-Year Total Return
--
52-week Low
May 07, 2025 - $47.86
52-week High
Nov 12, 2024 - $107.37
Valuation
Market Cap
$3.67B - Mid Cap
Enterprise Value
$3.16B
Price/Sales (TTM)
47.92
Price/Book (Q)
8.80
Dividends and Shares
Shares Outstanding
55.26M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arcellx.com
Phone Number
240 327 0630
Address
800 Bridge Parkway
Redwood City, CA 94065
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company’s lead... more
NASDAQ 06/11/2025 9:34AM Eastern Quotes delayed